Table: begin end state 1 5 non-cytoplasmic 6 52 transmembrane 53 64 non-cytoplasmic 65 88 transmembrane 89 108 cytoplasmic 109 142 transmembrane 143 153 non-cytoplasmic 154 179 transmembrane 180 180 non-cytoplasmic 181 188 cytoplasmic 189 191 non-cytoplasmic 192 217 transmembrane 218 236 non-cytoplasmic 237 262 transmembrane 263 263 cytoplasmic 264 264 non-cytoplasmic 265 285 transmembrane 286 299 cytoplasmic 300 321 transmembrane 322 327 non-cytoplasmic 328 332 cytoplasmic 333 375 transmembrane 376 381 non-cytoplasmic 382 407 transmembrane 408 418 cytoplasmic 419 443 transmembrane 444 456 non-cytoplasmic
Input: >GFF1039 MGLEEILVIAMFASFMGLLLLGFPVAWSLAGIGLLFAVLGYVLVEHFDANLWFTWDGTIG VLDARIYGIVANELMVALPLFIFMGIMLDRSGIAERLMHSLVRVLGPLRGGYAVTVVVVG ILLAASTGIVGASVALLGMLSIGPMLQANYNKSLAVGTACSVGTLGILIPPSIMLVLMAD RLGTSEASVGKLFMGALIPGMMLALMYILYIVIVAWLKKDFAPAPVNRPKLDARALLDVF WAVVPPLALIFAVLGSIFFGIATTTEASAVGAFGALLMAAASRRLNLPVLKDALYQTSRT AAFIFGIFIGATVFAAVLRGLGGDDVIRAALTGLPFGQTGVLLTVLAITFLLGFFLDWVE ITLIILPLVAPVLFSMGVDPLWFAILFALCLQTSFLTPPVGFALFYIKGVCPPGITTRDV YLGVLPYIVIQLIGLALVFYFAPLATWLPNEVYSQP
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server